These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 12796844)

  • 1. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
    Kaufmann AM; Backsch C; Schneider A; Dürst M
    Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
    DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
    Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade.
    Ledwaba T; Dlamini Z; Naicker S; Bhoola K
    Biol Chem; 2004 Aug; 385(8):671-82. PubMed ID: 15449703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on human papillomavirus vaccines for cervical cancer.
    Steller MA
    Curr Opin Investig Drugs; 2002 Jan; 3(1):37-47. PubMed ID: 12054070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT; Roden RB; Wu TC
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype.
    Arias-Pulido H; Joste N; Wheeler CM
    Genes Chromosomes Cancer; 2004 Aug; 40(4):277-84. PubMed ID: 15188450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in cervical cancer.
    Wani K; Nair CK
    Indian J Exp Biol; 2003 Aug; 41(8):789-96. PubMed ID: 15248474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventative and therapeutic vaccines for cervical cancer.
    Roden R; Wu TC
    Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
    Pillai MR; Nair MK
    Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV: from infection to cancer.
    Stanley MA; Pett MR; Coleman N
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic and therapeutic vaccine therapy in papillomavirus infections].
    Vinatier D; Cosson M; Dufour P
    Gynecol Obstet Fertil; 2000 May; 28(5):370-84. PubMed ID: 10893881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.
    Stern PL
    J Clin Virol; 2005 Mar; 32 Suppl 1():S72-81. PubMed ID: 15753015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.